GPER: A novel target for non-genomic estrogen action in the cardiovascular system

Pharmacological Research

Volumn 71, Issue , 2013, Pages 53-60

  Han, Guichun ^a,b   Li, Fen ^a,b,d   Yu, Xuan ^a,b   White, Richard E ^c  

^a Michael E DeBakey Institute   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c PHILADELPHIA COLLEGE OF OSTEOPATHIC MEDICINE   (United States)

^d HENAN NORMAL UNIVERSITY   (China)

Author keywords

cAMP; ERK1 2; GPER (GPR30); Smooth muscle cell growth; Vascular tone

Indexed keywords

CYCLIC AMP; ENDOTHELIN 1; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FULVESTRANT; G 1; G 15; G PROTEIN COUPLED ESTROGEN RECEPTOR; G PROTEIN COUPLED RECEPTOR; LARGE CONDUCTANCE CALCIUM ACTIVATED POTASSIUM CHANNEL; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; PROSTANOID; UNCLASSIFIED DRUG; VASODILATOR AGENT;

APOPTOSIS; BLOOD VESSEL TONE; CALCIUM MOBILIZATION; CARDIOVASCULAR EFFECT; CARDIOVASCULAR FUNCTION; CELL DIFFERENTIATION; CEREBROVASCULAR ACCIDENT; CONCENTRATION RESPONSE; CORONARY ARTERY DILATATION; DRUG EFFECT; DRUG MECHANISM; ENDOTHELIUM CELL; ENZYME INACTIVATION; HEART PROTECTION; HORMONE ACTION; HUMAN; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; RECEPTOR BLOCKING; REVIEW; SIGNAL TRANSDUCTION; VASCULAR SMOOTH MUSCLE;

ANIMALS; APOPTOSIS; CARDIOVASCULAR PHYSIOLOGICAL PHENOMENA; CARDIOVASCULAR SYSTEM; CELL PROLIFERATION; CYCLIC AMP; ESTROGENS; HUMANS; MAP KINASE SIGNALING SYSTEM; MUSCLE, SMOOTH; RECEPTORS, ESTROGEN; RECEPTORS, G-PROTEIN-COUPLED;

EID: 84876128831     PISSN: 10436618     EISSN: 10961186     Source Type: Journal    
DOI: 10.1016/j.phrs.2013.02.008     Document Type: Review

References (103)

1. C.R. Rosenfeld, R.E. White, T. Roy, and B.E. Cox Calcium-activated potassium channels and nitric oxide coregulate estrogen-induced vasodilation American Journal of Physiology Heart and Circulatory Physiology 279 2000 H319 H328
2. R.L. Santos, E.B. Marin, W.L. Goncalves, N.S. Bissoli, G.R. Abreu, and M.R. Moyses Sex differences in the coronary vasodilation induced by 17 beta-oestradiol in the isolated perfused heart from spontaneously hypertensive rats Acta Physiologica (Oxford, England) 200 2010 203 210
3. R. Raddino, C. Manca, E. Poli, R. Bolognesi, and O. Visioli Effects of 17 beta-estradiol on the isolated rabbit heart Archives Internationales de Pharmacodynamie et de Therapie 281 1986 57 65
4. + channels in coronary vasodilation induced by 17beta-estradiol in ischemic heart failure FASEB Journal 11 1997 793 799
5. W.A. Salhab, P.W. Shaul, B.E. Cox, and C.R. Rosenfeld Regulation of types I and III NOS in ovine uterine arteries by daily and acute estrogen exposure American Journal of Physiology Heart and Circulatory Physiology 278 2000 H2134 H2142
6. O. Lekontseva, S. Chakrabarti, Y. Jiang, C.C. Cheung, and S.T. Davidge Role of neuronal nitric-oxide synthase in estrogen-induced relaxation in rat resistance arteries Journal of Pharmacology and Experimental Therapeutics 339 2011 367 375
7. G. Abou-Mohamed, A. Elmarakby, G.O. Carrier, J.D. Catravas, R.W. Caldwell, and R.E. White Estradiol relaxes rat aorta via endothelium-dependent and -independent mechanisms Pharmacology 69 2003 20 26
8. G.G. Geary, D.N. Krause, and S.P. Duckles Estrogen reduces mouse cerebral artery tone through endothelial NOS- and cyclooxygenase-dependent mechanisms American Journal of Physiology Heart and Circulatory Physiology 279 2000 H511 H519
9. M.A. Belfort, G.R. Saade, M. Suresh, and Y.P. Vedernikov Effects of estradiol-17 beta and progesterone on isolated human omental artery from premenopausal nonpregnant women and from normotensive and preeclamptic pregnant women American Journal of Obstetrics and Gynecology 174 1996 246 253
10. A. Mugge, M. Riedel, M. Barton, M. Kuhn, and P.R. Lichtlen Endothelium independent relaxation of human coronary arteries by 17 beta-oestradiol in vitro Cardiovascular Research 27 1993 1939 1942
11. Ca channels through a cGMP-dependent mechanism Circulation Research 77 1995 936 942
12. G. Han, H. Ma, R. Chintala, K. Miyake, D.J. Fulton, and S.A. Barman Nongenomic, endothelium-independent effects of estrogen on human coronary smooth muscle are mediated by type I (neuronal) NOS and PI3-kinase-Akt signaling American Journal of Physiology Heart and Circulatory Physiology 293 2007 H314 H321
13. G. Han, H. Ma, R. Chintala, D.J. Fulton, S.A. Barman, and R.E. White Essential role of the 90-kilodalton heat shock protein in mediating nongenomic estrogen signaling in coronary artery smooth muscle Journal of Pharmacology and Experimental Therapeutics 329 2009 850 855
14. S.E. Reis, S.T. Gloth, R.S. Blumenthal, J.R. Resar, H.A. Zacur, and G. Gerstenblith Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women Circulation 89 1994 52 60
15. A.H. Chester, C. Jiang, J.A. Borland, M.H. Yacoub, and P. Collins Oestrogen relaxes human epicardial coronary arteries through non-endothelium-dependent mechanisms Coronary Artery Disease 6 1995 417 422
16. R.E. White, G. Han, C. Dimitropoulou, S. Zhu, K. Miyake, and D. Fulton Estrogen-induced contraction of coronary arteries is mediated by superoxide generated in vascular smooth muscle American Journal of Physiology Heart and Circulatory Physiology 289 2005 H1468 H1475
17. R.J. Pietras, and C.M. Szego Specific binding sites for oestrogen at the outer surfaces of isolated endometrial cells Nature 265 1977 69 72
18. C. Carmeci, D.A. Thompson, H.Z. Ring, U. Francke, and R.J. Weigel Identification of a gene (GPR30) with homology to the G-protein-coupled receptor superfamily associated with estrogen receptor expression in breast cancer Genomics 45 1997 607 617
19. Y. Takada, C. Kato, S. Kondo, R. Korenaga, and J. Ando Cloning of cDNAs encoding G protein-coupled receptor expressed in human endothelial cells exposed to fluid shear stress Biochemical and Biophysical Research Communications 240 1997 737 741
20. A.M. Kvingedal, and E.B. Smeland A novel putative G-protein-coupled receptor expressed in lung, heart and lymphoid tissue FEBS Letters 407 1997 59 62
21. M. Barton Position paper: the membrane estrogen receptor GPER-clues and questions Steroids 77 2012 935 942
22. Y. Mizukami In vivo functions of GPR30/GPER-1, a membrane receptor for estrogen: from discovery to functions in vivo Endocrine Journal 57 2010 101 107
23. E.R. Prossnitz, and M. Barton The G-protein-coupled estrogen receptor GPER in health and disease Nature Reviews Endocrinology 7 2011 715 726
24. J. Ford, A. Hajibeigi, M. Long, L. Hahner, C. Gore, and J.T. Hsieh GPR30 deficiency causes increased bone mass, mineralization, and growth plate proliferative activity in male mice Journal of Bone and Mineral Research 26 2011 298 307
25. T.J. Heino, A.S. Chagin, and L. Savendahl The novel estrogen receptor G-protein-coupled receptor 30 is expressed in human bone Journal of Endocrinology 197 2008 R1 R6
26. B.R. Weil, M.C. Manukyan, J.L. Herrmann, Y. Wang, A.M. Abarbanell, and J.A. Poynter Signaling via GPR30 protects the myocardium from ischemia/reperfusion injury Surgery 148 2010 436 443
27. S. Chakrabarti, and S.T. Davidge G-protein coupled receptor 30 (GPR30): a novel regulator of endothelial inflammation PLoS ONE 7 2012 e52357
28. M.V. Hofmeister, H.H. Damkier, B.M. Christensen, B. Olde, L.M. Fredrik Leeb-Lundberg, and R.A. Fenton 17beta-Estradiol induces nongenomic effects in renal intercalated cells through G protein-coupled estrogen receptor 1 American Journal of Physiology. Renal Physiology 302 2012 F358 F368
29. A. Wallacides, A. Chesnel, H. Ajj, M. Chillet, S. Flament, and H. Dumond Estrogens promote proliferation of the seminoma-like TCam-2 cell line through a GPER-dependent ERalpha36 induction Molecular and Cellular Endocrinology 350 2012 61 71
30. J. Isensee, L. Meoli, V. Zazzu, C. Nabzdyk, H. Witt, and D. Soewarto Expression pattern of G protein-coupled receptor 30 in LacZ reporter mice Endocrinology 150 2009 1722 1730
31. T. Funakoshi, A. Yanai, K. Shinoda, M.M. Kawano, and Y. Mizukami G protein-coupled receptor 30 is an estrogen receptor in the plasma membrane Biochemical and Biophysical Research Communications 346 2006 904 910
32. C.M. Revankar, H.D. Mitchell, A.S. Field, R. Burai, C. Corona, and C. Ramesh Synthetic estrogen derivatives demonstrate the functionality of intracellular GPR30 ACS Chemical Biology 2 2007 536 544
33. E. Deliu, G.C. Brailoiu, J.B. Arterburn, T.I. Oprea, K. Benamar, and N.J. Dun Mechanisms of G protein-coupled estrogen receptor-mediated spinal nociception Journal of Pain 13 2012 742 754
34. C. Otto, B. Rohde-Schulz, G. Schwarz, I. Fuchs, M. Klewer, and D. Brittain G protein-coupled receptor 30 localizes to the endoplasmic reticulum and is not activated by estradiol Endocrinology 149 2008 4846 4856
35. C.M. Revankar, D.F. Cimino, L.A. Sklar, J.B. Arterburn, and E.R. Prossnitz A transmembrane intracellular estrogen receptor mediates rapid cell signaling Science 307 2005 1625 1630
36. A. Madeo, and M. Maggiolini Nuclear alternate estrogen receptor GPR30 mediates 17beta-estradiol-induced gene expression and migration in breast cancer-associated fibroblasts Cancer Research 70 2010 6036 6046
37. E. Filardo, J. Quinn, Y. Pang, C. Graeber, S. Shaw, and J. Dong Activation of the novel estrogen receptor G protein-coupled receptor 30 (GPR30) at the plasma membrane Endocrinology 148 2007 3236 3245
38. S.B. Cheng, C.T. Graeber, J.A. Quinn, and E.J. Filardo Retrograde transport of the transmembrane estrogen receptor, G-protein-coupled-receptor-30 (GPR30/GPER) from the plasma membrane towards the nucleus Steroids 76 2011 892 896
39. B. Moy, R.J. Lee, and M. Smith Natural products in cancer chemotherapy: Hormones and related agents L.L. Brunton, Goodman & Gilman's The Pharmacolgical Basis of Therapeutics 2011 McGraw Hill New York 1755 1769
40. L. Shaw, M.J. Taggart, and C. Austin Mechanisms of 17 beta-oestradiol induced vasodilatation in isolated pressurized rat small arteries British Journal of Pharmacology 129 2000 555 565
41. K. Sudhir, T.M. Chou, W.L. Mullen, D. Hausmann, P. Collins, and P.G. Yock Mechanisms of estrogen-induced vasodilation: in vivo studies in canine coronary conductance and resistance arteries Journal of the American College of Cardiology 26 1995 807 814
42. M.R. Meyer, O. Baretella, E.R. Prossnitz, and M. Barton Dilation of epicardial coronary arteries by the G protein-coupled estrogen receptor agonists G-1 and ICI 182,780 Pharmacology 86 2010 58 64
43. W. Keung, M.L. Chan, E.Y. Ho, P.M. Vanhoutte, and R.Y. Man Non-genomic activation of adenylyl cyclase and protein kinase G by 17beta-estradiol in vascular smooth muscle of the rat superior mesenteric artery Pharmacological Research 64 2011 509 516
44. E.R. Prossnitz, J.B. Arterburn, and L.A. Sklar GPR30: a G protein-coupled receptor for estrogen Molecular and Cellular Endocrinology 265-266 2007 138 142
45. U.E. Martensson, S.A. Salehi, S. Windahl, M.F. Gomez, K. Sward, and J. Daszkiewicz-Nilsson Deletion of the G protein-coupled receptor 30 impairs glucose tolerance, reduces bone growth, increases blood pressure, and eliminates estradiol-stimulated insulin release in female mice Endocrinology 150 2009 687 698
46. E. Haas, I. Bhattacharya, E. Brailoiu, M. Damjanovic, G.C. Brailoiu, and X. Gao Regulatory role of G protein-coupled estrogen receptor for vascular function and obesity Circulation Research 104 2009 288 291
47. E.R. Prossnitz, T.I. Oprea, L.A. Sklar, and J.B. Arterburn The ins and outs of GPR30: a transmembrane estrogen receptor Journal of Steroid Biochemistry and Molecular Biology 109 2008 350 353
48. S.H. Lindsey, J.A. Cohen, K.B. Brosnihan, P.E. Gallagher, and M.C. Chappell Chronic treatment with the G protein-coupled receptor 30 agonist G-1 decreases blood pressure in ovariectomized mRen2.Lewis rats Endocrinology 150 2009 3753 3758
49. B.R. Broughton, A.A. Miller, and C.G. Sobey Endothelium-dependent relaxation by G protein-coupled receptor 30 agonists in rat carotid arteries American Journal of Physiology Heart and Circulatory Physiology 298 2010 H1055 H1061
50. M.R. Meyer, E.R. Prossnitz, and M. Barton The G protein-coupled estrogen receptor GPER/GPR30 as a regulator of cardiovascular function Vascular Pharmacology 55 2011 17 25
51. X. Yu, H. Ma, S.A. Barman, A.T. Liu, M. Sellers, and J.N. Stallone Activation of G protein-coupled estrogen receptor induces endothelium- independent relaxation of coronary artery smooth muscle American Journal of Physiology Endocrinology and Metabolism 301 2011 E882 E888
52. S.H. Lindsey, K.A. Carver, E.R. Prossnitz, and M.C. Chappell Vasodilation in response to the GPR30 agonist G-1 is not different from estradiol in the mRen2.Lewis female rat Journal of Cardiovascular Pharmacology 57 2011 598 603
53. B. Das, and C. Sarkar Similarities between ischemic preconditioning and 17beta-estradiol mediated cardiomyocyte KATP channel activation leading to cardioprotective and antiarrhythmic effects during ischemia/reperfusion in the intact rabbit heart Journal of Cardiovascular Pharmacology 47 2006 277 286
54. A.M. Deschamps, E. Murphy, and J. Sun Estrogen receptor activation and cardioprotection in ischemia reperfusion injury Trends in Cardiovascular Medicine 20 2010 73 78
55. A.M. Deschamps, and E. Murphy Activation of a novel estrogen receptor, GPER, is cardioprotective in male and female rats American Journal of Physiology Heart and Circulatory Physiology 297 2009 H1806 H1813
56. V.H. Patel, J. Chen, M. Ramanjaneya, E. Karteris, E. Zachariades, and P. Thomas G-protein coupled estrogen receptor 1 expression in rat and human heart: protective role during ischaemic stress International Journal of Molecular Medicine 26 2010 193 199
57. J.C. Bopassa, M. Eghbali, L. Toro, and E. Stefani A novel estrogen receptor GPER inhibits mitochondria permeability transition pore opening and protects the heart against ischemia-reperfusion injury American Journal of Physiology Heart and Circulatory Physiology 298 2010 H16 H23
58. R.L. Brunsing, and E.R. Prossnitz Induction of interleukin-10 in the T helper type 17 effector population by the G protein coupled estrogen receptor (GPER) agonist G-1 Immunology 134 2011 93 106
59. A.G. Recchia, E.M. De Francesco, A. Vivacqua, D. Sisci, M.L. Panno, and S. Ando The G protein-coupled receptor 30 is up-regulated by hypoxia-inducible factor-1alpha (HIF-1alpha) in breast cancer cells and cardiomyocytes Journal of Biological Chemistry 286 2011 10773 10782
60. G. Sharma, and E.R. Prossnitz Mechanisms of estradiol-induced insulin secretion by the G protein-coupled estrogen receptor GPR30/GPER in pancreatic beta-cells Endocrinology 152 2011 3030 3039
61. B. Zhang, S. Subramanian, S. Dziennis, J. Jia, M. Uchida, and K. Akiyoshi Estradiol and G1 reduce infarct size and improve immunosuppression after experimental stroke Journal of Immunology 184 2010 4087 4094
62. S. Patkar, T.D. Farr, E. Cooper, F.J. Dowell, and H.V. Carswell Differential vasoactive effects of oestrogen, oestrogen receptor agonists and selective oestrogen receptor modulators in rat middle cerebral artery Neuroscience Research 71 2011 78 84
63. W.W. Batenburg, P.M. Jansen, A.J. van den Bogaerdt, and A.H. J Danser Angiotensin II-aldosterone interaction in human coronary microarteries involves GPR30, EGFR, and endothelial NO synthase Cardiovascular Research 94 2012 136 143
64. C.L. Chiu, S. Lujic, C. Thornton, A. O'Loughlin, A. Makris, and A. Hennessy Menopausal hormone therapy is associated with having high blood pressure in postmenopausal women: observational cohort study PLoS ONE 7 2012 e40260
65. M.R. Meyer, A.S. Field, N.L. Kanagy, M. Barton, and E.R. Prossnitz GPER regulates endothelin-dependent vascular tone and intracellular calcium Life Sciences 91 2012 623 627
66. A. McCurley, P.W. Pires, S.B. Bender, M. Aronovitz, M.J. Zhao, and D. Metzger Direct regulation of blood pressure by smooth muscle cell mineralocorticoid receptors Nature Medicine 18 2012 1429 1433
67. R. Gros, Q. Ding, B. Liu, J. Chorazyczewski, and R.D. Feldman Aldosterone mediates its rapid effects in vascular endothelial cells through Gper/Gpr30 Activation American Journal of Physiology Cell Physiology 2013 10.1152/ajpcell.00203.2012 in press
68. M.R. Meyer, K. Amann, A.S. Field, C. Hu, H.J. Hathaway, and N.L. Kanagy Deletion of G protein-coupled estrogen receptor increases endothelial vasoconstriction Hypertension 59 2012 507 512
69. M. Feletou, Y. Huang, and P.M. Vanhoutte Endothelium-mediated control of vascular tone: COX-1 and COX-2 products British Journal of Pharmacology 164 2011 894 912
70. A. Virdis, L. Ghiadoni, S. Pinto, M. Lombardo, F. Petraglia, and A. Gennazzani Mechanisms responsible for endothelial dysfunction associated with acute estrogen deprivation in normotensive women Circulation 101 2000 2258 2263
71. A. Virdis, L. Ghiadoni, and S. Taddei Human endothelial dysfunction: EDCFs Pflugers Archiv 459 2010 1015 1023
72. D.A. Smiley, and R.A. Khalil Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels Current Medicinal Chemistry 16 2009 1863 1887
73. J. Teng, Z.Y. Wang, E.R. Prossnitz, and D.E. Bjorling The G protein-coupled receptor GPR30 inhibits human urothelial cell proliferation Endocrinology 149 2008 4024 4034
74. M. Li, and J.N. Stallone Estrogen potentiates vasopressin-induced contraction of female rat aorta by enhancing cyclooxygenase-2 and thromboxane function American Journal of Physiology Heart and Circulatory Physiology 289 2005 H1542 H1550
75. E.A. Ariazi, E. Brailoiu, S. Yerrum, H.A. Shupp, M.J. Slifker, and H.E. Cunliffe The G protein-coupled receptor GPR30 inhibits proliferation of estrogen receptor-positive breast cancer cells Cancer Research 70 2010 1184 1194
76. A.A. Tica, E.C. Dun, O.S. Tica, X. Gao, J.B. Arterburn, and G.C. Brailoiu G protein-coupled estrogen receptor 1-mediated effects in the rat myometrium American Journal of Physiology Cell Physiology 301 2011 C1262 C1269
77. E.J. Filardo, J.A. Quinn, A.R. Frackelton Jr., and K.I. Bland Estrogen action via the G protein-coupled receptor, GPR30: stimulation of adenylyl cyclase and cAMP-mediated attenuation of the epidermal growth factor receptor-to-MAPK signaling axis Molecular Endocrinology 16 2002 70 84
78. P. Thomas, Y. Pang, E.J. Filardo, and J. Dong Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells Endocrinology 146 2005 624 632
79. A. Balhuizen, R. Kumar, S. Amisten, I. Lundquist, and A. Salehi Activation of G protein-coupled receptor 30 modulates hormone secretion and counteracts cytokine-induced apoptosis in pancreatic islets of female mice Molecular and Cellular Endocrinology 320 2010 16 24
80. D.J. Darkow, L. Lu, and R.E. White Estrogen relaxation of coronary artery smooth muscle is mediated by nitric oxide and cGMP American Journal of Physiology 272 1997 H2765 H2773
81. K.L. Chambliss, Q. Wu, S. Oltmann, E.S. Konaniah, M. Umetani, and K.S. Korach Non-nuclear estrogen receptor alpha signaling promotes cardiovascular protection but not uterine or breast cancer growth in mice Journal of Clinical Investigation 120 2010 2319 2330
82. B. Chandrasekar, S. Nattel, and J.F. Tanguay Coronary artery endothelial protection after local delivery of 17beta-estradiol during balloon angioplasty in a porcine model: a potential new pharmacologic approach to improve endothelial function Journal of the American College of Cardiology 38 2001 1570 1576
83. A. Holm, B. Baldetorp, B. Olde, L.M. Leeb-Lundberg, and B.O. Nilsson The GPER1 agonist G-1 attenuates endothelial cell proliferation by inhibiting DNA synthesis and accumulating cells in the S and G2 phases of the cell cycle Journal of Vascular Research 48 2011 327 335
84. E.M. Rzucidlo, K.A. Martin, and R.J. Powell Regulation of vascular smooth muscle cell differentiation Journal of Vascular Surgery 45 Suppl. A 2007 A25 A32
85. G.K. Owens, M.S. Kumar, and B.R. Wamhoff Molecular regulation of vascular smooth muscle cell differentiation in development and disease Physiological Reviews 84 2004 767 801
86. M. Hosono, M. Ueda, S. Suehiro, Y. Sasaki, T. Shibata, and K. Hattori Neointimal formation at the sites of anastomosis of the internal thoracic artery grafts after coronary artery bypass grafting in human subjects: an immunohistochemical analysis Journal of Thoracic and Cardiovascular Surgery 120 2000 319 328
87. J. Kawagoe, M. Ohmichi, S. Tsutsumi, T. Ohta, K. Takahashi, and H. Kurachi Mechanism of the divergent effects of estrogen on the cell proliferation of human umbilical endothelial versus aortic smooth muscle cells Endocrinology 148 2007 6092 6099
88. R.K. Dubey, E.K. Jackson, D.G. Gillespie, L.C. Zacharia, B. Imthurn, and P.J. Keller Clinically used estrogens differentially inhibit human aortic smooth muscle cell growth and mitogen-activated protein kinase activity Arteriosclerosis, Thrombosis, and Vascular Biology 20 2000 964 972
89. K. Takahashi, M. Ohmichi, M. Yoshida, K. Hisamoto, S. Mabuchi, and E. Arimoto-Ishida Both estrogen and raloxifene cause G1 arrest of vascular smooth muscle cells Journal of Endocrinology 178 2003 319 329
90. D. Sivritas, M.U. Becher, T. Ebrahimian, O. Arfa, S. Rapp, and A. Bohner Antiproliferative effect of estrogen in vascular smooth muscle cells is mediated by Kruppel-like factor-4 and manganese superoxide dismutase Basic Research in Cardiology 106 2011 563 575
91. C.H. Selzman, J.S. Gaynor, A.S. Turner, T.A. Whitehill, L.D. Horwitz, and A.H. Harken Estrogen replacement inhibits intimal hyperplasia and the accumulation and effects of transforming growth factor beta1 Journal of Surgical Research 80 1998 380 385
92. M.L. Foegh, S. Asotra, M.H. Howell, and P.W. Ramwell Estradiol inhibition of arterial neointimal hyperplasia after balloon injury Journal of Vascular Surgery 19 1994 722 726
93. Y. Zhu, Z. Bian, P. Lu, R.H. Karas, L. Bao, and D. Cox Abnormal vascular function and hypertension in mice deficient in estrogen receptor beta Science 295 2002 505 508
94. M.D. Iafrati, R.H. Karas, M. Aronovitz, S. Kim, T.R. Sullivan Jr., and D.B. Lubahn Estrogen inhibits the vascular injury response in estrogen receptor alpha-deficient mice Nature Medicine 3 1997 545 548
95. M. Nakagawa, T. Naruko, Y. Ikura, R. Komatsu, Y. Iwasa, and C. Kitabayashi A decline in platelet activation and inflammatory cell infiltration is associated with the phenotypic redifferentiation of neointimal smooth muscle cells after bare-metal stent implantation in acute coronary syndrome Journal of Atherosclerosis and Thrombosis 17 2010 675 687
96. H.J. Li, Z. Haque, Q. Lu, L. Li, R. Karas, and M. Mendelsohn Steroid receptor coactivator 3 is a coactivator for myocardin, the regulator of smooth muscle transcription and differentiation Proceedings of the National Academy of Sciences of the United States of America 104 2007 4065 4070
97. C.J. Pepine, W.W. Nichols, and D.F. Pauly Estrogen and different aspects of vascular disease in women and men Circulation Research 99 2006 459 461
98. E.J. Filardo, J.A. Quinn, K.I. Bland, and A.R. Frackelton Jr. Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF Molecular Endocrinology 14 2000 1649 1660
99. E.J. Filardo, J.A. Quinn, and E. Sabo Association of the membrane estrogen receptor, GPR30, with breast tumor metastasis and transactivation of the epidermal growth factor receptor Steroids 73 2008 870 873
100. M. Pupo, A. Pisano, R. Lappano, M.F. Santolla, E.M. De Francesco, and S. Abonante Bisphenol A induces gene expression changes and proliferative effects through GPER in breast cancer cells and cancer-associated fibroblasts Environmental Health Perspectives 120 2012 1177 1182
101. F. Gao, X. Ma, A.B. Ostmann, and S.K. Das GPR30 activation opposes estrogen-dependent uterine growth via inhibition of stromal ERK1/2 and estrogen receptor alpha (ERalpha) phosphorylation signals Endocrinology 152 2011 1434 1447
102. T.M. Ahola, N. Alkio, T. Manninen, and T. Ylikomi Progestin and G protein-coupled receptor 30 inhibit mitogen-activated protein kinase activity in MCF-7 breast cancer cells Endocrinology 143 2002 4620 4626
103. J. Lubig, C. Lattrich, A. Springwald, J. Haring, S. Schuler, and O. Ortmann Effects of a combined treatment with GPR30 agonist G-1 and herceptin on growth and gene expression of human breast cancer cell lines Cancer Investigation 30 2012 372 379